<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 01 Mar 2021 16:51:50 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2021“创新力·中国行” ——吹响医药创新集结号，奏响生命科学的中国乐章！</title><link>https://mp.weixin.qq.com/s/iqihZyD7YUzzWYJ7d63bdQ</link><description></description><content:encoded><![CDATA[2021“创新力·中国行” ——吹响医药创新集结号，奏响生命科学的中国乐章！]]></content:encoded><pubDate>Mon, 01 Mar 2021 16:10:30 +0800</pubDate></item><item><title>【瞩目】科伦又一品种首家过评，18款注射剂亮眼</title><link>https://mp.weixin.qq.com/s/Tj44FokPoVU2c8VQqPIy3A</link><description></description><content:encoded><![CDATA[【瞩目】科伦又一品种首家过评，18款注射剂亮眼]]></content:encoded><pubDate>Mon, 01 Mar 2021 16:10:30 +0800</pubDate></item><item><title>【市场】20亿注射剂大品种，齐鲁过评了</title><link>https://mp.weixin.qq.com/s/OiAwXSvUhK5odcn8KYmSJA</link><description></description><content:encoded><![CDATA[【市场】20亿注射剂大品种，齐鲁过评了]]></content:encoded><pubDate>Mon, 01 Mar 2021 16:10:30 +0800</pubDate></item><item><title>【重磅】先声拿下30亿大品种，罗氏六成市场危险</title><link>https://mp.weixin.qq.com/s/1NHLuQ-kk6HdYWwvo1Yenw</link><description></description><content:encoded><![CDATA[【重磅】先声拿下30亿大品种，罗氏六成市场危险]]></content:encoded><pubDate>Mon, 01 Mar 2021 16:10:30 +0800</pubDate></item><item><title>科伦、正大天晴......98个新药获批临床！东阳光药进攻60亿明星药，流感1类新药来袭</title><link>https://mp.weixin.qq.com/s/RCary2bOvkheBonH9aU-oA</link><description></description><content:encoded><![CDATA[科伦、正大天晴......98个新药获批临床！东阳光药进攻60亿明星药，流感1类新药来袭]]></content:encoded><pubDate>Sun, 28 Feb 2021 08:09:21 +0800</pubDate></item><item><title>销售费用“爆雷”，290家上市药企被查！11个注射剂被撤网，红日、亚宝……获国家级表彰</title><link>https://mp.weixin.qq.com/s/xU253aREglNICa3onlep4w</link><description></description><content:encoded><![CDATA[销售费用“爆雷”，290家上市药企被查！11个注射剂被撤网，红日、亚宝……获国家级表彰]]></content:encoded><pubDate>Sat, 27 Feb 2021 08:13:15 +0800</pubDate></item><item><title>80个新药燃爆4000亿中成药市场！独家产品年年暴涨，康缘、天士力1类新药来了</title><link>https://mp.weixin.qq.com/s/z6FjI-fRaT4Rnc6IJQMP9w</link><description></description><content:encoded><![CDATA[80个新药燃爆4000亿中成药市场！独家产品年年暴涨，康缘、天士力1类新药来了]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【重磅】恒瑞领军地位遇危机！科伦入局暴涨150%的抗血栓注射剂</title><link>https://mp.weixin.qq.com/s/iaEf0rvusbbYY-U9y-OSQQ</link><description></description><content:encoded><![CDATA[【重磅】恒瑞领军地位遇危机！科伦入局暴涨150%的抗血栓注射剂]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【瞩目】东阳光药猛攻70亿胰岛素大品种，甘李国产独家将被打破</title><link>https://mp.weixin.qq.com/s/aGslgmspJJm7RZQ6vMb81g</link><description></description><content:encoded><![CDATA[【瞩目】东阳光药猛攻70亿胰岛素大品种，甘李国产独家将被打破]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【焦点】10亿止痛大品种恩华获批了！原研九成市场节节败退</title><link>https://mp.weixin.qq.com/s/H55GnEClKOBI82RrqRsJ7w</link><description></description><content:encoded><![CDATA[【焦点】10亿止痛大品种恩华获批了！原研九成市场节节败退]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>奥赛康发威了！11个品种抢首仿，7款创新药亮相，首家过评率超60%</title><link>https://mp.weixin.qq.com/s/GZY41hg9woavu3IIMAHqeQ</link><description></description><content:encoded><![CDATA[奥赛康发威了！11个品种抢首仿，7款创新药亮相，首家过评率超60%]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【瞩目】扬子江18个注射剂领跑过评榜，将拿下30亿大品种</title><link>https://mp.weixin.qq.com/s/FVQWVXznvwZYH2nRLlKnpA</link><description></description><content:encoded><![CDATA[【瞩目】扬子江18个注射剂领跑过评榜，将拿下30亿大品种]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【聚焦】人福今年首个ANDA获批，国内30亿市场暂无首仿</title><link>https://mp.weixin.qq.com/s/e8GS-ZLCCnid8cjLG6_xHw</link><description></description><content:encoded><![CDATA[【聚焦】人福今年首个ANDA获批，国内30亿市场暂无首仿]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【关注】重磅儿童药，这家四川药企拿下首仿后过评</title><link>https://mp.weixin.qq.com/s/JllXFwiC5lLclpDKZ5xrIQ</link><description></description><content:encoded><![CDATA[【关注】重磅儿童药，这家四川药企拿下首仿后过评]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>241家药企2020成绩单出炉！12家净利润超20亿，以岭、大参林……突破10亿，这16家首亏</title><link>https://mp.weixin.qq.com/s/nzSUwx7sA0ha8_kLKYA2kA</link><description></description><content:encoded><![CDATA[241家药企2020成绩单出炉！12家净利润超20亿，以岭、大参林……突破10亿，这16家首亏]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【获批】10亿注射剂激战！齐鲁、海思科同日过评</title><link>https://mp.weixin.qq.com/s/X0yE0i6E9A6c0nwmQdqpLw</link><description></description><content:encoded><![CDATA[【获批】10亿注射剂激战！齐鲁、海思科同日过评]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【审评】扬子江、恒瑞……围攻30亿注射剂！石四药也来了</title><link>https://mp.weixin.qq.com/s/5ZVWU-AILMEaohSE4SkThQ</link><description></description><content:encoded><![CDATA[【审评】扬子江、恒瑞……围攻30亿注射剂！石四药也来了]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【关注】暴涨200%！石药“瞄准”抗肿瘤药，原研药再受冲击</title><link>https://mp.weixin.qq.com/s/1vNUMZcxKnnj903fmbJMgg</link><description></description><content:encoded><![CDATA[【关注】暴涨200%！石药“瞄准”抗肿瘤药，原研药再受冲击]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>齐鲁“猛攻”创新药！15款1类新药在研，$2.35亿引进抗癌药，23个集采品种助力创新</title><link>https://mp.weixin.qq.com/s/uVSKF9dkWY5SXnCMyUeO1A</link><description></description><content:encoded><![CDATA[齐鲁“猛攻”创新药！15款1类新药在研，$2.35亿引进抗癌药，23个集采品种助力创新]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item><item><title>【瞩目】汇宇制药将拿下$5亿抗肿瘤注射剂</title><link>https://mp.weixin.qq.com/s/n5n5wEb2Rhah8hp7tLO1CA</link><description></description><content:encoded><![CDATA[【瞩目】汇宇制药将拿下$5亿抗肿瘤注射剂]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item></channel></rss>